The VIDAS is sold by Biomerieux in the Procalcitonin Tests market. The procalcitonin (PCT) in vitro diagnostic device determines the quantity of PCT in the blood. Our blood typically contains relatively lower levels of PCT. However, PCT can be released into the bloodstream by cells in many different parts of the body in response to a major bacterial infection. A significant infection or sepsis may therefore be indicated by a high level of PCT in the blood. The chemiluminescence enzyme immunoassay (CLEIA) is the predominant method employed for detecting PCT in patient samples. Other test types used to measure PCT include fluorescence immunoassays, latex enhanced immunoturbidimetric assays, and lateral flow immunochromatographic test strips.

Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.

For a complete picture of Biomerieux’ Procalcitonin Tests device pricing in Japan, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

This micro pricing report leverages GlobalData’s Global Brand Pricing tracker, which estimates brand-level selling prices (including discounts) of key medical devices in 30 countries. GlobalData’s Medical Intelligence Center uses a proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data. Medical device pricing data can be tracked by market, company, and brand globally.